These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18191510)

  • 1. Aiming for a moving target: challenges with impactor measurements of MDI aerosols.
    Stein SW
    Int J Pharm; 2008 May; 355(1-2):53-61. PubMed ID: 18191510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Electrostatic Controls on MDI Size Distribution Measurements.
    Stein SW; Rasmussen J; Walls S; Schultz DW; Oakley C; Drake JB
    AAPS PharmSciTech; 2019 Apr; 20(5):170. PubMed ID: 31004248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of heated inlet extensions to the TSI 3306/3321 system: comparison with the Andersen cascade impactor and next generation impactor.
    Myrdal PB; Mogalian E; Mitchell J; Nagel M; Wright C; Kiser B; Prell M; Woessner M; Stein SW
    J Aerosol Med; 2006; 19(4):543-54. PubMed ID: 17196082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: a scoping study with the "Alberta" idealized throat (AIT) inlet.
    Mitchell J; Copley M; Sizer Y; Russell T; Solomon D
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):188-97. PubMed ID: 22857270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent.
    Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
    AAPS PharmSciTech; 2009; 10(1):252-7. PubMed ID: 19291411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of single versus multiple actuations on the particle size distribution of beclometasone dipropionate metered-dose inhalers.
    Feddah MR; Davies NM
    J Pharm Pharmacol; 2003 Aug; 55(8):1055-61. PubMed ID: 12956894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions.
    Stein SW; Myrdal PB
    J Pharm Sci; 2004 Aug; 93(8):2158-75. PubMed ID: 15236462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers.
    Mogalian E; Myrdal PB
    Drug Dev Ind Pharm; 2005 Dec; 31(10):977-85. PubMed ID: 16316853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of solution-based pressurised metered-dose inhaler aerosols with an optical particle counter.
    Kuhli M; Weiss M; Steckel H
    Eur J Pharm Biopharm; 2010 Aug; 75(3):393-8. PubMed ID: 20347974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size distribution of chromate paint aerosol generated in a bench-scale spray booth.
    Sabty-Daily RA; Hinds WC; Froines JR
    Ann Occup Hyg; 2005 Jan; 49(1):33-45. PubMed ID: 15596421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of droplet evaporation rate on resulting in vitro performance parameters of pressurized metered dose inhalers.
    Sheth P; Grimes MR; Stein SW; Myrdal PB
    Int J Pharm; 2017 Aug; 528(1-2):360-371. PubMed ID: 28599855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers.
    Harris JA; Stein SW; Myrdal PB
    AAPS PharmSciTech; 2006 Mar; 7(1):E138-E145. PubMed ID: 28290035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic charge characteristics of aerosols produced from metered dose inhalers.
    Kwok PC; Glover W; Chan HK
    J Pharm Sci; 2005 Dec; 94(12):2789-99. PubMed ID: 16258995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the TSI Model 3306 Impactor Inlet with the Andersen Cascade Impactor: solution metered dose inhalers.
    Myrdal PB; Stein SW; Mogalian E; Hoye W; Gupta A
    Drug Dev Ind Pharm; 2004 Sep; 30(8):859-68. PubMed ID: 15521331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size aspects of metered-dose inhaler aerosols.
    Kim CS; Trujillo D; Sackner MA
    Am Rev Respir Dis; 1985 Jul; 132(1):137-42. PubMed ID: 4014858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new Aerodynamic Particle Sizer Spectrometer for size distribution measurements of solution metered dose inhalers.
    Stein SW; Myrdal PB; Gabrio BJ; Obereit D; Beck TJ
    J Aerosol Med; 2003; 16(2):107-19. PubMed ID: 12823905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.